Whereas this is informative to define the mechanism by which RET mutations and altered GDNF-RET signalling impact cancer initiation and progression [40, 44, 45], a comprehensive analysis of RET signalling in neurons is needed to further our understanding of the implications of deregulation of RET signalling in neuromuscular diseases. The gene discussed is GDNF; the disease is cancer.